Find out more about Andrew Weickhardt's experience
Andrew Weickhardt's highlights
FEATURED Journal article
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.
Read moreAndrew Weickhardt's selected work
Real-world first-line systemic therapy patterns in metastatic castration-resistant prostat..
Journal article
Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage
Journal article
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX ..
Journal article
Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castra..
Journal article
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequen..
Journal article
Changes in prescribing habits for the treatment of metastatic renal clear cell carcinoma (..
Journal article
Andrew Weickhardt's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 33 for Andrew Weickhardt.
Credentials
Positions
Honorary
Clinical Pathology